Pfizer is considering seeking to register its COVID-19 vaccine in Russia, the TASS news agency cited the US drugmaker as saying on Tuesday.
Russia has registered two COVID-19 vaccines for domestic use, both developed by Russian research institutes. They have been used to inoculate over a million people since Moscow’s mass-vaccination program began last month, authorities say.
“Pfizer is considering the possibility of applying to register its COVID-19 vaccine candidate in the Russian Federation,” TASS cited the company as saying in a statement.
Pfizer, which developed the vaccine with Germany’s BioNTech , did not immediately respond to a request for comment.
On Monday, the Interfax news agency cited Pfizer as saying that this year it would only ship its vaccine to countries where it has already signed government-level contracts. No contract for delivery has been signed with Russia.
Coronavirus: US to require negative COVID-19 test for intl. air passengers: ReportThe head of the U.S. Centers for Disease Control and Prevention (CDC) is expected to sign an order on Tuesday expanding coronavirus testing ... Coronavirus
Coronavirus: UAE vaccinates 108,401 against COVID-19 in 24 hoursThe UAE vaccinated 108,401 people against the coronavirus over the last 24 hours, the Ministry of Health announced on Tuesday.The ministry said the ... Coronavirus
Lebanon records highest single day coronavirus deaths, prepares for complete shutdownLebanon reported its highest daily number of new coronavirus deaths since the outbreak began in December 2019, with the health ministry reporting 32 ... Coronavirus